AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca hat ähnlich zu Pfizer einen Deal mit der US-Regierung abgeschlossen. Patienten erhalten bis zu 80 % Rabatte auf den Listenpreis. Dafür bekommt das Unternehmen 3 Jahre Zollbefreiung.
Astrazeneca (AZN) reached $201.21 at the closing of the latest trading day, reflecting a -1.55% change compared to its last close.
UBS and Citi both maintain buy ratings on the Anglo-Swedish drugmaker ahead of its first-quarter results, with a rich pipeline of clinical catalysts...
9 April 2026Results of Annual General Meeting held on 9 April 2026AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed...
Though both dominate oncology, a stronger growth outlook and clearer targets may give AstraZeneca an edge over Merck.
